help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on July 10, 2007
Molecular Endocrinology, doi:10.1210/me.2007-0259
Molecular Endocrinology Vol. 0, No. 2007 200702591-
doi:10.1210/me.2007-0259
Copyright © 2007 by the Endocrine Society.
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
21/11/2605    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Manolagas, S. C.
Right arrow Articles by Almeida, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Manolagas, S. C.
Right arrow Articles by Almeida, M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Bone Diseases
Hazardous Substances DB
*GLUCOSE

Submitted on May 17, 2007
Accepted on June 29, 2007

Gone with the Wnts: {beta}-catenin, TCF, FOXO, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism

Stavros C. Manolagas* and Maria Almeida

Division of Endocrinology & Metabolism and the Center of Osteoporosis and Metabolic Bone Diseases, Department of Medicine, University of Arkansas for Medical Sciences and the Central Arkansas Veterans Health Care System, Little Rock, AR 72205

* To whom correspondence should be addressed. E-mail: manolagasstavros{at}uams.edu.

The Wnt/{beta}-catenin signaling pathway affects several biological processes ranging from embryonic development, patterning, and post-embryonic stem cell fate, to bone formation and insulin secretion in adulthood. {beta}-catenin mediates canonical Wnt signaling by binding to and activating members of the T cell factor (TCF) transcription factor family. Similar to the Wnt/{beta}-catenin pathway, oxidative stress influences fundamental cellular processes including stem cell fate and has been linked to aging and the development of age-related diseases. However, the molecular details of the pathogenetic effects of oxidative stress on the homeostasis of many different tissues remain unclear. {beta}-catenin has been recently implicated as a pivotal molecule in defense against oxidative stress by serving as a co-factor of the forkhead box O (FOXO) transcription factors. In addition, it has been shown that oxidative stress is a pivotal pathogenetic factor of age-related bone loss and strength in mice, leading to, among other changes, a decrease in osteoblast number and bone formation. These particular cellular changes evidently result from diversion of the limited pool of {beta}-catenin from TCF- to FOXO-mediated transcription in osteoblastic cells. Fascinatingly, attenuation of Wnt-mediated transcription, resulting from an autosomal dominant missense mutation in LRP6--a co-receptor for the Wnt-signaling pathway has been linked recently genetically not only to premature osteoporosis, but also to coronary artery disease as well as several features of the metabolic syndrome including hyperlipidemia, hypertension, and diabetes, but not obesity. In this minireview, we highlight evidence linking the age-associated oxidative stress with FOXOs, Wnt/{beta}-catenin signaling, osteoblastogenesis, adipogenesis, osteoporosis and several features of the metabolic syndrome. We hypothesize that antagonism of Wnt-signaling by oxidative stress with increasing age may be a common molecular mechanism contributing to the development not only of involutional osteoporosis, but several pathologies like atherosclerosis, insulin resistance, and hyperlipidemia--all of which become more prevalent with advancing age.


Key words: aging • reactive oxygen species • osteoporosis • atherosclerosis • hyperlipidemia • diabetes • metabolic syndrome • gene transcription • transcription factors




This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
C. Weidinger, K. Krause, A. Klagge, S. Karger, and D. Fuhrer
Forkhead box-O transcription factor: critical conductors of cancer's fate
Endocr. Relat. Cancer, December 1, 2008; 15(4): 917 - 929.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
T. Jin and L. Liu
Minireview: The Wnt Signaling Pathway Effector TCF7L2 and Type 2 Diabetes Mellitus
Mol. Endocrinol., November 1, 2008; 22(11): 2383 - 2392.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. C. Manolagas
De-fense! De-fense! De-fense: Scavenging H2O2 While Making Cholesterol
Endocrinology, July 1, 2008; 149(7): 3264 - 3266.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society